Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$15.78 - $24.77 $3.82 Million - $5.99 Million
-241,871 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$19.4 - $27.42 $510,452 - $721,475
-26,312 Reduced 9.81%
241,871 $5.9 Million
Q1 2021

May 14, 2021

BUY
$25.02 - $54.99 $390,612 - $858,503
15,612 Added 6.18%
268,183 $6.92 Million
Q4 2020

Feb 02, 2021

BUY
$41.04 - $56.79 $29,836 - $41,286
727 Added 0.29%
252,571 $13.5 Million
Q3 2020

Nov 05, 2020

BUY
$36.42 - $57.0 $285,897 - $447,450
7,850 Added 3.22%
251,844 $10.4 Million
Q2 2020

Aug 12, 2020

SELL
$39.26 - $52.73 $278,392 - $373,908
-7,091 Reduced 2.82%
243,994 $11.8 Million
Q1 2020

May 12, 2020

SELL
$31.65 - $46.87 $906,519 - $1.34 Million
-28,642 Reduced 10.24%
251,085 $10.6 Million
Q4 2019

Jan 27, 2020

BUY
$36.21 - $51.4 $2.08 Million - $2.95 Million
57,324 Added 25.77%
279,727 $12 Million
Q3 2019

Oct 31, 2019

BUY
$22.22 - $44.01 $2.16 Million - $4.28 Million
97,232 Added 77.68%
222,403 $8 Million
Q2 2019

Aug 15, 2019

BUY
$23.32 - $28.12 $479,715 - $578,456
20,571 Added 19.67%
125,171 $3.35 Million
Q1 2019

May 03, 2019

SELL
$16.17 - $27.38 $24,255 - $41,070
-1,500 Reduced 1.41%
104,600 $2.81 Million
Q4 2018

Feb 08, 2019

SELL
$14.32 - $22.92 $150,360 - $240,660
-10,500 Reduced 9.01%
106,100 $1.72 Million
Q3 2018

Nov 13, 2018

SELL
$13.03 - $21.81 $125,088 - $209,376
-9,600 Reduced 7.61%
116,600 $2.42 Million
Q2 2018

Aug 15, 2018

SELL
$15.07 - $22.34 $381,271 - $565,202
-25,300 Reduced 16.7%
126,200 $1.93 Million
Q1 2018

May 11, 2018

SELL
$22.47 - $32.33 $164,031 - $236,009
-7,300 Reduced 4.6%
151,500 $3.4 Million
Q4 2017

Feb 06, 2018

BUY
$26.84 - $39.14 $150,304 - $219,184
5,600 Added 3.66%
158,800 $4.78 Million
Q3 2017

Nov 15, 2017

BUY
$29.49 - $38.37 $4.52 Million - $5.88 Million
153,200
153,200 $5.77 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.